Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Hematopoietic Cell Transplantation From Donor- Sources of Matched-sibling, Matched-unrelated, or Haploidentical- Family Donors Using Uniform Conditioning Regimen of Busulfan, Fludarabine, and Antithymocyte Globulin for Acute Myeloid Leukemia in Remission - an Observational Study

NCT07155382 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT07155382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Hematopoietic Cell Transplantation From Donor- Sources of Matched-sibling, Matched-unrelated, or Haploidentical- Family Donors Using Uniform Conditioning Regimen of Busulfan, Fludarabine, and Antithymocyte Globulin for Acute Myeloid Leukemia in Remission - an Observational Study
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
April 4, 2017
Completion date
August 22, 2024
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)